CHI3L1 and respiratory tract infectious disorder: YKL-40 is expressed in the lung and serum of patients with bronchial asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, sarcoidosis, lung cancer, respiratory infections, tuberculosis and cystic fibrosis [21–24].